Spero Therapeutics (SPRO) Q1 2026 Earnings

26MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.55
-0.19
0.17
0.53

Details

Expected EPS
-0.2
Actual EPS
0.53
Surprise EPS
0.73
Surprise Percent
+365%

Description

Spero Therapeutics (SPRO) has reported earnings of 0.53 per share for Q1 2026.

0 Comments

Share your thoughts